Abstract
Background
Cognitive status classification (e.g. dementia, cognitive impairment without dementia, and normal) based on cognitive performance questionnaires has been widely used in population-based studies, providing insight into the population dynamics of dementia. However, researchers have raised concerns about the accuracy of cognitive assessments. MRI and CSF biomarkers may provide improved classification, but the potential improvement in classification in population-based studies is relatively unknown.
Methods
Data come from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). We examined whether the addition of MRI and CSF biomarkers improved cognitive status classification based on cognitive status questionnaires (MMSE). We estimated several multinomial logistic regression models with different combinations of MMSE and CSF/MRI biomarkers. Based on these models, we also predicted prevalence of each cognitive status category using a model with MMSE only and a model with MMSE + MRI + CSF measures and compared them to diagnosed prevalence.
Results
Our analysis showed a slight improvement in variance explained (pseudo-R2) between the model with MMSE only and the model including MMSE and MRI/CSF biomarkers; the pseudo-R2 increased from .401 to .445. Additionally, in evaluating differences in predicted prevalence for each cognitive status, we found a small improvement in the predicted prevalence of cognitively normal individuals between the MMSE only model and the model with MMSE and CSF/MRI biomarkers (3.1% improvement). We found no improvement in the correct prediction of dementia prevalence.
Conclusion
MRI and CSF biomarkers, while important for understanding dementia pathology in clinical research, were not found to substantially improve cognitive status classification based on cognitive status performance, which may limit adoption in population-based surveys due to costs, training, and invasiveness associated with their collection.
Funder
National Institute on Aging
Publisher
Public Library of Science (PLoS)
Reference31 articles.
1. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults;J Feeney;J Alzheimers Dis JAD,2016
2. Comparison of Methods for Algorithmic Classification of Dementia Status in the Health and Retirement Study.;KZ Gianattasio;Epidemiol Camb Mass.,2019
3. Trends in the Risk of Cognitive Impairment in the United States, 1996–2014.;JM Hale;Epidemiol Camb Mass.,2020
4. Biomarkers in dementia: clinical utility and new directions;RM Ahmed;J Neurol Neurosurg Psychiatry,2014
5. Diagnostic biomarkers of Alzheimer’s disease: A state-of-the-art review.;R Khoury;Biomark Neuropsychiatry.,2019
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献